225 related articles for article (PubMed ID: 31671200)
1. Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium.
Huckfeldt RM; Vavvas DG
Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):656-659. PubMed ID: 31671200
[TBL] [Abstract][Full Text] [Related]
2. Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.
Mukhopadhyay C; Boyce TM; Gehrs KM; Folk JC; Mullins RF; Luo Y; Kreder K; Sohn EH
Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):100-110. PubMed ID: 35533330
[TBL] [Abstract][Full Text] [Related]
3. Maculopathy caused by pentosan polysulfate.
Rosenberg D; Sarraf D; Chaudhary V
CMAJ; 2021 May; 193(18):E645. PubMed ID: 33941523
[No Abstract] [Full Text] [Related]
4. VISUAL AND ANATOMICAL CHANGES AFTER DRUG CESSATION IN PENTOSAN POLYSULFATE SODIUM-ASSOCIATED MACULOPATHY.
Gupta PR; Grewal DS
Retin Cases Brief Rep; 2023 Sep; 17(5):507-510. PubMed ID: 37643033
[TBL] [Abstract][Full Text] [Related]
5. Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020.
Paredes Mogica JA; De EJB
Urology; 2021 Jan; 147():109-118. PubMed ID: 33045286
[TBL] [Abstract][Full Text] [Related]
6. Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study.
Jain N; Liao A; Garg SJ; Patel SN; Wykoff CC; Yu HJ; London NJS; Khurana RN; Zacks DN;
Ophthalmol Retina; 2022 Mar; 6(3):219-227. PubMed ID: 34298229
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy.
Case AW; Anderson MJ; Sayomac LE
Optom Vis Sci; 2021 Jun; 98(6):552-556. PubMed ID: 34039907
[TBL] [Abstract][Full Text] [Related]
8. Re: Review - Proctor JG. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
Foote J; Shiromani S; Jain N
Can J Urol; 2024 Jun; 31(3):11867-11868. PubMed ID: 38912936
[No Abstract] [Full Text] [Related]
9. Re: Letter to the Editor - Proctor JG. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
Proctor JG
Can J Urol; 2024 Jun; 31(3):11869-11870. PubMed ID: 38912937
[No Abstract] [Full Text] [Related]
10. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
Proctor JG
Can J Urol; 2023 Dec; 30(6):11732-11739. PubMed ID: 38104330
[TBL] [Abstract][Full Text] [Related]
11. Pentosan polysulfate maculopathy.
Lindeke-Myers A; Hanif AM; Jain N
Surv Ophthalmol; 2022; 67(1):83-96. PubMed ID: 34000253
[TBL] [Abstract][Full Text] [Related]
12. Pentosan Polysulfate Maculopathy versus Inherited Macular Dystrophies: Comparative Assessment with Multimodal Imaging.
Barnes AC; Hanif AM; Jain N
Ophthalmol Retina; 2020 Dec; 4(12):1196-1201. PubMed ID: 32446908
[TBL] [Abstract][Full Text] [Related]
13. Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.
Christiansen JS; Barnes AC; Berry DE; Jain N
Can J Ophthalmol; 2022 Feb; 57(1):16-22. PubMed ID: 33722504
[TBL] [Abstract][Full Text] [Related]
14. POTENTIAL NEW-ONSET CLINICALLY DETECTABLE PENTOSAN POLYSULFATE MACULOPATHY YEARS AFTER DRUG CESSATION.
Barnett JM; Jain N
Retin Cases Brief Rep; 2022 Nov; 16(6):724-726. PubMed ID: 33229920
[TBL] [Abstract][Full Text] [Related]
15. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort.
Jain N; Li AL; Yu Y; VanderBeek BL
Br J Ophthalmol; 2020 Aug; 104(8):1093-1097. PubMed ID: 31694837
[TBL] [Abstract][Full Text] [Related]
16. RAPID PENTOSAN POLYSULFATE SODIUM MACULOPATHY PROGRESSION.
Somisetty S; Santina A; Abraham N; Lu A; Morales VR; Sarraf D
Retin Cases Brief Rep; 2023 Nov; 17(6):660-663. PubMed ID: 35385434
[TBL] [Abstract][Full Text] [Related]
17. Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.
Hanif AM; Shah R; Yan J; Varghese JS; Patel SA; Cribbs BE; O'Keefe G; Hendrick AM; Shantha JG; Hubbard GB; Patel PS; Rao P; Yeh S; Jain N
Ophthalmology; 2019 Oct; 126(10):1464-1466. PubMed ID: 31004677
[No Abstract] [Full Text] [Related]
18. Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.
Shah R; Simonett JM; Lyons RJ; Rao RC; Pennesi ME; Jain N
JAMA Ophthalmol; 2020 Aug; 138(8):894-900. PubMed ID: 32644147
[TBL] [Abstract][Full Text] [Related]
19. Association Between Pentosan Polysulfate Sodium and Retinal Disorders.
McGwin G; MacLennan P; Owsley C
JAMA Ophthalmol; 2022 Jan; 140(1):37-42. PubMed ID: 34792558
[TBL] [Abstract][Full Text] [Related]
20. Risk of maculopathy with pentosan polysulfate sodium use.
Bae SS; Sodhi M; Maberley D; Kezouh A; Etminan M
Br J Clin Pharmacol; 2022 Jul; 88(7):3428-3433. PubMed ID: 35277990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
